Overview
Description
Petlife Pharmaceuticals Inc. is a biotechnology company specializing in the development, production, and marketing of innovative pharmaceutical products for companion animals. The company's primary focus is on improving the health and well-being of pets by providing advanced treatment options. Among its notable developments is a line of oncology drugs designed to enhance the quality of life for pets suffering from cancer. Petlife Pharmaceuticals operates primarily within the pet healthcare sector, which intersects with the broader veterinary medicine industry. This market is significant due to the increasing emphasis on pet health and a growing demand for quality veterinary care. Petlife Pharmaceuticals plays a crucial role by contributing cutting-edge solutions that address specific health concerns of animals, thereby aiding veterinarians and pet owners in managing pet health more effectively.
About
CEO
Mr. Sebastian Serrell-Watts
Employees
1
Address
8033 Sunset Boulevard
Suite 867
Los Angeles, 90046, CA
United States
Suite 867
Los Angeles, 90046, CA
United States
Phone
424-216-6807
Website
—
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
MIC code
PINX